1. Virani, S.S.; Alonso, A.; Benjamin, E.J.; Bittencourt, M.S.; Callaway, C.W.; Carson, A.P.; Chamberlain, A.M.; Chang, A.R.; Cheng, S.; Delling, F.N.; et al. Heart disease and stroke statistics—2020 Update: A report from the American Heart Association. Circulation 2020, 141, e139–e596. [CrossRef] [PubMed]
2. Maron, D.J.; Hochman, J.S.; Reynolds, H.R.; Bangalore, S.; O’Brien, S.M.; Boden, W.E.; Chaitman, B.R.; Senior, R.; López-Sendón, J.; Alexander, K.P.; et al. Initial invasive or conservative strategy for stable coronary disease. N. Engl. J. Med. 2020, 382, 1395–1407. [CrossRef] [PubMed]
3. Antman, E.M.; Braunwald, E. Managing stable ischemic heart disease. N. Engl. J. Med. 2020, 382, 1468–1470. [CrossRef] [PubMed]
4. Kohsaka, S.; Kumamaru, H.; Inohara, T.; Amano, T.; Akasaka, T.; Miyata, H.; Motomura, N.; Nakamura, M. Outcome of percutaneous coronary intervention in relation to the institutional volume of coronary artery bypass surgery. J. Clin. Med. 2020, 9, 1267. [CrossRef] [PubMed]
5. Alkhouli, M.; Alqahtani, F.; Kalra, A.; Gafoor, S.; Alhajji, M.; Alreshidan, M.; Holmes, D.R.; Lerman, A. Trends in characteristics and outcomes of patients undergoing coronary revascularization in the united states, 2003–2016. JAMA Netw. Open 2020, 3, e1921326. [CrossRef]
6. Baig, S.S.; Altman, D.G.; Taggart, D.P. Major geographical variations in elective coronary revascularization by stents or surgery in England. Eur. J. Cardio Thoracic Surg. 2015, 47, 855–859. [CrossRef]
7. Whelton, P.K.; Carey, R.M.; Aronow, W.S.; Casey, D.E.; Collins, K.J.; Dennison Himmelfarb, C.; DePalma, S.M.; Gidding, S.; Jamerson, K.A.; Jones, D.W.; et al. 2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Pr. J. Am. Coll. Cardiol. 2018, 71, e127–e248. [CrossRef]
8. Wright, J.T.; Williamson, J.D.; Whelton, P.K.; Snyder, J.K.; Sink, K.M.; Rocco, M.V.; Reboussin, D.M.; Rahman, M.; Oparil, S.; Lewis, C.E.; et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 2015, 373, 2103–2116. [CrossRef]
9. Bress, A.P.; Tanner, R.M.; Hess, R.; Colantonio, L.D.; Shimbo, D.; Muntner, P. Generalizability of SPRINT Results to the U.S. Adult Population. J. Am. Coll. Cardiol. 2016, 67, 463–472. [CrossRef]
10. Douros, A.; Tölle, M.; Ebert, N.; Gaedeke, J.; Huscher, D.; Kreutz, R.; Kuhlmann, M.K.; Martus, P.; Mielke, N.; Schneider, A.; et al. Control of blood pressure and risk of mortality in a cohort of older adults: The Berlin Initiative Study. Eur. Heart J. 2019, 40, 2021–2028. [CrossRef]
11. Bress, A.P.; Kramer, H.; Khatib, R.; Beddhu, S.; Cheung, A.K.; Hess, R.; Bansal, V.K.; Cao, G.; Yee, J.; Moran, A.E.; et al. Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (systolic blood pressure intervention trial) intensive blood pressure regimen in the United States: Projections from NHANES (National Health and Nutrition Examination). Circulation 2017, 135, 1617–1618. [CrossRef] [PubMed]
12. Camici, P.G.; Merz, N.B.; Beltrame, J.; Brown, D.L.; Crea, F.; Kaski, J.C.; Maas, A.; Ong, P.; Pepine, C.; Rimoldi, O.; et al. Commentary—The ISCHEMIA trial. Int. J. Cardiol. 2020, 304, 1–4. [CrossRef] [PubMed]
13. Morrow, A.; Sidik, N.; Berry, C. ISCHEMIA: New questions from a landmark trial. Cardiovasc. Res. 2020, 116, e23–e25. [CrossRef] [PubMed]
14. Baumbach, A.; Bourantas, C.V.; Serruys, P.W.; Wijns, W. The year in cardiology: Coronary interventions.Eur. Heart J. 2020, 41, 394–405. [CrossRef] [PubMed]
15. Mathias, I.S.; Riaz, H. ISCHEMIA Trial: A hope or a hype for patients with stable coronary artery disease?Am. J. Med. 2019. [CrossRef] [PubMed]
16. Rothwell, P.M. External validity of randomised controlled trials: To whom do the results of this trial apply?Lancet (Lond.) 2005, 365, 82–93. [CrossRef]
17. Bosch, X.; Delgado, V.; Verbal, F.; Bórquez, E.; Loma-Osorio, P.; Díez-Aja, S.; Miranda-Guardiola, F.; Sanchís, J. Causes of ineligibility in randomized controlled trials and long-term mortality in patients with non-ST-segment elevation acute coronary syndromes. Int. J. Cardiol. 2008, 124, 86–91. [CrossRef]
18. Inohara, T.; Kohsaka, S.; Miyata, H.; Ueda, I.; Maekawa, Y.; Fukuda, K.; Cohen, D.J.; Kennedy, K.F.; Rumsfeld, J.S.; Spertus, J.A. Performance and validation of the U.S. NCDR Acute kidney injury prediction model in Japan. J. Am. Coll. Cardiol. 2016, 67, 1715–1722. [CrossRef]
19. Inohara, T.; Kohsaka, S.; Miyata, H.; Ueda, I.; Ishikawa, S.; Ohki, T.; Nishi, Y.; Hayashida, K.; Maekawa, Y.; Kawamura, A.; et al. Appropriateness ratings of percutaneous coronary intervention in Japan and its association with the trend of noninvasive testing. JACC Cardiovasc. Interv. 2014, 7, 1000–1009. [CrossRef]
20. Inohara, T.; Miyata, H.; Ueda, I.; Maekawa, Y.; Fukuda, K.; Kohsaka, S. Use of Intra-aortic balloon pump in a japanese multicenter percutaneous coronary intervention registry. JAMA Intern. Med. 2015, 175, 1980–1982. [CrossRef]
21. Hochman, J.S.; Reynolds, H.R.; Bangalore, S.; O’Brien, S.M.; Alexander, K.P.; Senior, R.; Boden, W.E.; Stone, G.W.; Goodman, S.G.; Lopes, R.D.; et al. Baseline characteristics and risk profiles of participants in the ISCHEMIA randomized clinical trial. JAMA Cardiol. 2019, 10016, 273–286. [CrossRef] [PubMed]
22. Rao, S.V.; McCoy, L.A.; Spertus, J.A.; Krone, R.J.; Singh, M.; Fitzgerald, S.; Peterson, E.D. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: A report using an expanded bleeding definition from the national cardiovascular data registry CathPCI registry. JACC Cardiovasc. Interv. 2013, 6, 897–904. [CrossRef] [PubMed]
23. Mehta, R.L.; Kellum, J.A.; Shah, S.V.; Molitoris, B.A.; Ronco, C.; Warnock, D.G.; Levin, A. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit. Care 2007, 11, R31. [CrossRef] [PubMed]
24. Kennedy-Martin, T.; Curtis, S.; Faries, D.; Robinson, S.; Johnston, J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 2015, 16, 495. [CrossRef] [PubMed]
25. Van Spall, H.G.C.; Toren, A.; Kiss, A.; Fowler, R.A. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. J.Am. Med. Assoc. 2007, 297, 1233–1240. [CrossRef]
26. Steg, P.G.; López-Sendón, J.; Lopez de Sa, E.; Goodman, S.G.; Gore, J.M.; Anderson, F.A.; Himbert, D.; Allegrone, J.; Van de Werf, F. GRACE investigators external validity of clinical trials in acute myocardial infarction. Arch. Intern. Med. 2007, 167, 68–73. [CrossRef]
27. Kohsaka, S.; Miyata, H.; Ueda, I.; Masoudi, F.A.; Peterson, E.D.; Maekawa, Y.; Kawamura, A.; Fukuda, K.; Roe, M.T.; Rumsfeld, J.S. An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio interhospital Cardiovascular Studies (JCD-KiCS). Am. Heart J. 2015, 170, 1077–1085. [CrossRef]
28. Brenes-Salazar, J.A.; Forman, D.E. Advances in percutaneous coronary interventions for elderly patients.Prog. Cardiovasc. Dis. 2014, 57, 176–186. [CrossRef]
29. Cockburn, J.; Hildick-Smith, D.; Trivedi, U.; de Belder, A. Coronary revascularisation in the elderly. Heart2017, 103, 316–324. [CrossRef]
30. Bagai, A.; Eberg, M.; Koh, M.; Cheema, A.N.; Yan, A.T.; Dhoot, A.; Bhavnani, S.P.; Wijeysundera, H.C.; Bhatia, R.S.; Kaul, P.; et al. Population-based study on patterns of cardiac stress testing after percutaneous coronary intervention. Circ. Cardiovasc. Qual. Outcomes 2017, 10, 1–9. [CrossRef]
31. Seki, T.; Takeuchi, M.; Miki, R.; Kawakami, K. Follow-up tests and outcomes for patients undergoing percutaneous coronary intervention: Analysis of a Japanese administrative database. Heart Vessel. 2019, 34, 33–43. [CrossRef] [PubMed]
32. Steg, P.G.; Greenlaw, N.; Tendera, M.; Tardif, J.C.; Ferrari, R.; Al-Zaibag, M.; Dorian, P.; Hu, D.; Shalnova, S.; Sokn, F.J.; et al. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease data from the international observational CLARIFY registry. JAMA Intern. Med. 2014, 174, 1651–1659. [CrossRef] [PubMed]
33. Maddox, T.M.; Chan, P.S.; Spertus, J.A.; Tang, F.; Jones, P.; Ho, P.M.; Bradley, S.M.; Tsai, T.T.; Bhatt, D.L.; Peterson, P.N. Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: Insights from the NCDR (National Cardiovascular Data Registry). J. Am. Coll. Cardiol. 2014, 63, 539–546. [CrossRef] [PubMed]
34. Takaro, T.; Peduzzi, P.; Detre, K.M.; Hultgren, H.N.; Murphy, M.L.; van der Bel-Kahn, J.; Thomsen, J.; Meadows, W.R. Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation 1982, 66, 14–22. [CrossRef]
35. Phillips, H.R.; O’Connor, C.M.; Rogers, J. Revascularization for heart failure. Am. Heart J. 2007, 153, 65–73. [CrossRef]
36. Murphy, M.L.; Hultgren, H.N.; Detre, K.; Thomsen, J.; Takaro, T. Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration Cooperative Study. N. Engl. J. Med. 1977, 297, 621–627. [CrossRef]
37. Yusuf, S.; Zucker, D.; Peduzzi, P.; Fisher, L.D.; Takaro, T.; Kennedy, J.W.; Davis, K.; Killip, T.; Passamani, E.; Norris, R. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet (Lond.) 1994, 344, 563–570. [CrossRef]
38. Fihn, S.D.; Gardin, J.M.; Abrams, J.; Berra, K.; Blankenship, J.C.; Dallas, A.P.; Douglas, P.S.; Foody, J.M.; Gerber, T.C.; Hinderliter, A.L.; et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012, 126, e354–e471. [CrossRef]
39. Knuuti, J.; Wijns, W.; Saraste, A.; Capodanno, D.; Barbato, E.; Funck-Brentano, C.; Prescott, E.; Storey, R.F.; Deaton, C.; Cuisset, T.; et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 2019, 1–71. [CrossRef]
40. Koskinas, K.C.; Ndrepepa, G.; Räber, L.; Karagiannis, A.; Kufner, S.; Zanchin, T.; Hieber, J.; Hunziker, L.; Mayer, K.; Byrne, R.A.; et al. Prognostic impact of periprocedural myocardial infarction in patients undergoing elective percutaneous coronary interventions. Circ. Cardiovasc. Interv. 2018, 11, 1–11. [CrossRef]
41. Zeitouni, M.; Silvain, J.; Guedeney, P.; Kerneis, M.; Yan, Y.; Overtchouk, P.; Barthelemy, O.; Hauguel-Moreau, M.; Choussat, R.; Helft, G.; et al. Periprocedural myocardial infarction and injury in elective coronary stenting. Eur. Heart J. 2018, 39, 1100–1109. [CrossRef] [PubMed]
論文の公開元へ
